➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Boehringer Ingelheim
Mallinckrodt
Moodys
Medtronic

Last Updated: June 7, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for TAMOXIFEN


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for TAMOXIFEN (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $6,791,049
INSIDE ANOTHER STORE $37,403,462
[disabled in preview] $107,929,446
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 81,987
INSIDE ANOTHER STORE 331,560
[disabled in preview] 1,333,951
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $1,170,804
MEDICARE $26,008,866
[disabled in preview] $124,944,286
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for TAMOXIFEN
Drug Units Sold Trends for TAMOXIFEN

Annual Sales Revenues and Units Sold for TAMOXIFEN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
TAMOXIFEN   Start Trial   Start Trial 2017
TAMOXIFEN   Start Trial   Start Trial 2016
TAMOXIFEN   Start Trial   Start Trial 2015
TAMOXIFEN   Start Trial   Start Trial 2014
TAMOXIFEN   Start Trial   Start Trial 2013
TAMOXIFEN   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Baxter
Mallinckrodt
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.